Pietro Dulbecco

Strictures in Crohn's Disease: From Pathophysiology to Treatment.

Journal: Digestive diseases and sciences

Published: October 28, 2019

Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Journal: Annals of gastroenterology

Published: May 19, 2017

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.

Journal: European journal of internal medicine

Published: October 05, 2016

Ilaprazole for the treatment of gastro-esophageal reflux.

Journal: Expert opinion on pharmacotherapy

Published: September 07, 2016

Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 20, 2016

Are proton pump inhibitors really so dangerous?

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 27, 2016

Barriers against split-dose bowel preparation for colonoscopy.

Journal: Gut

Published: November 07, 2015

Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 24, 2014

Polyp and endoscopist-related factors influencing complication rates in difficult colonic polypectomies: results of a multicenter observational study.

Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne

Published: March 14, 2014

DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: November 26, 2013

Strictures in Crohn's Disease: From Pathophysiology to Treatment.

Strictures in Crohn's Disease: From Pathophysiology to Treatment.

Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Drugs for improving esophageal mucosa defense: where are we now and where are we going?

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.

Ilaprazole for the treatment of gastro-esophageal reflux.

Ilaprazole for the treatment of gastro-esophageal reflux.

Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.

Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.

Are proton pump inhibitors really so dangerous?

Are proton pump inhibitors really so dangerous?

Barriers against split-dose bowel preparation for colonoscopy.

Barriers against split-dose bowel preparation for colonoscopy.

Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab.

Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab.

Polyp and endoscopist-related factors influencing complication rates in difficult colonic polypectomies: results of a multicenter observational study.

Polyp and endoscopist-related factors influencing complication rates in difficult colonic polypectomies: results of a multicenter observational study.

DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.

DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.

Therapeutic potential of curcumin in digestive diseases.

Therapeutic potential of curcumin in digestive diseases.

Adalimumab in active ulcerative colitis: a "real-life" observational study.

Adalimumab in active ulcerative colitis: a "real-life" observational study.